ALMDT Stock Overview
Median Technologies SA develops and markets software products and platforms for medical image analysis in France, the United States, Canada, the United Kingdom, China, and internationally.
Median Technologies Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||€11.10|
|52 Week High||€18.32|
|52 Week Low||€9.30|
|1 Month Change||-11.91%|
|3 Month Change||-7.19%|
|1 Year Change||-24.49%|
|3 Year Change||780.95%|
|5 Year Change||-7.03%|
|Change since IPO||10.12%|
Recent News & Updates
Is Median Technologies (EPA:ALMDT) Using Too Much Debt?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
|ALMDT||FR Healthcare Services||FR Market|
Return vs Industry: ALMDT underperformed the French Healthcare Services industry which returned -12% over the past year.
Return vs Market: ALMDT underperformed the French Market which returned -5.4% over the past year.
|ALMDT Average Weekly Movement||9.3%|
|Healthcare Services Industry Average Movement||7.4%|
|Market Average Movement||6.0%|
|10% most volatile stocks in FR Market||10.2%|
|10% least volatile stocks in FR Market||3.5%|
Stable Share Price: ALMDT is more volatile than 75% of French stocks over the past 3 months, typically moving +/- 9% a week.
Volatility Over Time: ALMDT's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of French stocks.
About the Company
Median Technologies SA develops and markets software products and platforms for medical image analysis in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iBiops, an end-to-end AI-powered technology software as a medical device that integrates and optimizes the entire medical imaging workflow; and iSee for image analysis services in clinical trials. It also provides imaging contract research services, such as study start up, image and clinical data management, scientific consulting, independent reviews, image data processing and site support, and study close-out for studies.
Median Technologies Fundamentals Summary
|ALMDT fundamental statistics|
Is ALMDT overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|ALMDT income statement (TTM)|
|Cost of Revenue||€17.80m|
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
|Earnings per share (EPS)||-1.25|
|Net Profit Margin||-92.99%|
How did ALMDT perform over the long term?See historical performance and comparison
Is Median Technologies undervalued compared to its fair value and its price relative to the market?
Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PB vs Industry
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate ALMDT's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate ALMDT's fair value for valuation analysis.
Price To Earnings Ratio
PE vs Industry: ALMDT is unprofitable, so we can't compare its PE Ratio to the European Healthcare Services industry average.
PE vs Market: ALMDT is unprofitable, so we can't compare its PE Ratio to the French market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate ALMDT's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: ALMDT is overvalued based on its PB Ratio (34.8x) compared to the FR Healthcare Services industry average (2.6x).
How is Median Technologies forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
Future Growth Score2/6
Future Growth Score 2/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ALMDT is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: ALMDT is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: ALMDT is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: ALMDT's revenue (31.4% per year) is forecast to grow faster than the French market (5.8% per year).
High Growth Revenue: ALMDT's revenue (31.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ALMDT's Return on Equity is forecast to be high in 3 years time
How has Median Technologies performed over the past 5 years?
Past Performance Score0/6
Past Performance Score 0/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ALMDT is currently unprofitable.
Growing Profit Margin: ALMDT is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: ALMDT is unprofitable, and losses have increased over the past 5 years at a rate of 1.8% per year.
Accelerating Growth: Unable to compare ALMDT's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ALMDT is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (-3%).
Return on Equity
High ROE: ALMDT has a negative Return on Equity (-390.68%), as it is currently unprofitable.
How is Median Technologies's financial position?
Financial Health Score5/6
Financial Health Score 5/6
Short Term Liabilities
Long Term Liabilities
Stable Cash Runway
Forecast Cash Runway
Financial Position Analysis
Short Term Liabilities: ALMDT's short term assets (€47.5M) exceed its short term liabilities (€27.3M).
Long Term Liabilities: ALMDT's short term assets (€47.5M) exceed its long term liabilities (€17.2M).
Debt to Equity History and Analysis
Debt Level: ALMDT has more cash than its total debt.
Reducing Debt: ALMDT's debt to equity ratio has increased from 1.2% to 316.8% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ALMDT has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: ALMDT has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 1.1% each year
What is Median Technologies's current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Future Dividend Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate ALMDT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate ALMDT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if ALMDT's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ALMDT's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as ALMDT has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mr. Fredrik Brag founded Median Technologies S.A. in 2002 and served as its Chairman and President until April 2019 and serves as its Chief Executive Officer and General Manager. Mr. Brag has been Director...
CEO Compensation Analysis
Compensation vs Market: Insufficient data to establish whether Fredrik's total compensation is reasonable compared to companies of similar size in the French market.
Compensation vs Earnings: Fredrik's compensation has increased whilst the company is unprofitable.
Experienced Management: ALMDT's management team is considered experienced (3.5 years average tenure).
Experienced Board: ALMDT's board of directors are considered experienced (6.5 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 5.5%.
Median Technologies SA's employee growth, exchange listings and data sources
- Name: Median Technologies SA
- Ticker: ALMDT
- Exchange: ENXTPA
- Founded: 2002
- Industry: Health Care Technology
- Sector: Healthcare
- Implied Market Cap: €171.714m
- Shares outstanding: 15.47m
- Website: https://www.mediantechnologies.com
Number of Employees
- Median Technologies SA
- 1800, Route des Crêtes
- Provence-Alpes-Côte d'Azur
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/05/23 00:00|
|End of Day Share Price||2022/05/23 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.